| Company Name | Paige |
| Founded | 2017 |
| Head office | New York |
| Website | https://www.page.ai |
| Contact |
Pathology products by Paige
Subspeciality: Breast pathology
Modality: Histopathology
Source: Public
No key features available
Paige Breast Detect & Neoplasm highlights foci suspicious for cancer and pre-cancerous neoplasms. For use with digitized H&E stained breast biopsy & excision images. It is the responsibility of a qualified pathologist to employ appropriate procedures to assure the quality of the images obtained and use manual visualization and re-evaluate the product’s results before incorporating in the final diagnosis. Results of the device shall only be considered after a professional pathologist’s initial review of the entire WSI.
Subspeciality: Breast pathology
Modality: Histopathology
Source: Public
No key features available
Identifies individual mitotic figures, locates the mitotic hotspot, and automatically calculates mitotic density.
Subspeciality: Breast pathology
Modality: Histopathology
Source:
No key features available
Detects foci that are suspicious for breast cancer metastasis on WSI from lymph node specimens. If concerning morphology is detected, it indicates the foci suspicious for cancer. It is the responsibility of a qualified pathologist to employ appropriate procedures to assure the quality of the images.
Subspeciality: Breast pathology
Modality: Histopathology
Source: Public
No key features available
AI assay that can measure HER2 expression from H&E samples, including the identification of HER-2 low patients.
Subspeciality: Uropathology
Modality: Histopathology
Source: Public
No key features available
Paige Prostate Detect is a software only device intended to assist pathologists in the detection of foci that are suspicious for cancer during the review of scanned whole slide images (WSI) from prostate needle biopsies prepared from hematoxylin & eosin (H&E) stained formalin-fixed paraffin embedded (FFPE) tissue. After initial diagnostic review of the WSI by the pathologist, if Paige Prostate detects tissue morphology suspicious for cancer, it provides coordinates (X,Y) on a single location on the image with the highest likelihood of having cancer for further review by the pathologist.
Subspeciality: Uropathology
Modality: Histopathology
Source: Public
Prostate cancer grading
Paige Prostate Grade & Quantify is offered and sold as part of the Paige Prostate Suite. Categorizes areas suspicious for cancer by Gleason pattern, providing a primary and secondary Gleason grade prediction, as well as a percentage and linear measurement of tumor burden.
Subspeciality: Uropathology
Modality: Histopathology
Source:
No key features available
Paige Prostate PNI is offered and sold as part of the Paige Prostate Suite.
Subspeciality: Gastrointestinal pathology
Modality: Histopathology
Source:
No key features available
Paige Colon Detect identifies foci suspicious for colon carcinoma and high-grade dysplasia (HGD).
Subspeciality: Uropathology
Modality: Histopathology
Source: Public
Disease specific biomarkers
Paige Prostate Biomarker Panel detects foci of prostate carcinoma that are likely positive for mutations on digital images from prostate biopsies & resections. If morphological phenotypes consistent with the following mutations are detected, it will classify the sample as positive. Androgen Receptor (AR) amplification: AR Compound tumor suppressor genes alterations, includes alterations in Tumour protein p53 (TP53), Phosphatase and tensin homolog (PTEN), Retinoblastoma protein 1 (RB1).